Fatty Liver Disease
The goal of the Stanford Fatty Liver Disease Program is to provide innovative and personalized care to patients with non-alcoholic fatty liver diseases. We have developed specific care pathways for the management of these increasingly common liver diseases.
We treat the following conditions:
- Non alcoholic Fatty Liver Disease (NAFLD)
- Hepatic Steatosis
- Non alcoholic steatohepatitis NASH
- NASH Cirrhosis
We have extensive experience in selecting the right patients for the right trials.
We have a team of dedicated hepatologists and support staff who have extensive expertise in taking care of patients with fatty liver diseases.